10/23/2026 | Press release | Distributed by Public on 10/23/2026 05:00
| ☒ |
Preliminary Proxy Statement
|
| ☐ |
Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
| ☐ |
Definitive Proxy Statement
|
| ☐ |
Definitive Additional Materials
|
| ☐ |
Soliciting Material under Rule 14a-12
|
|
|
☒ |
No fee required.
|
|
|
☐ |
Fee paid previously with preliminary materials.
|
|
|
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
1. |
To adopt and approve amendments to our Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our shares of common stock, by a ratio ranging from any whole number between 1-for-5 and 1-for-12, as determined by our Board of Directors (the "Board") in its discretion, subject to the Board's authority to abandon such amendments (the "Reverse Stock Split Proposal"); and
|
|
|
2. |
To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation of proxies in the event that there are insufficient votes for, or otherwise in connection with, the adoption and approval of Proposal 1.
|
|
|
1. |
You may submit a proxy to vote over the Internet. If you have Internet access, you may submit a proxy to vote from any location in the world at www.proxyvote.com, by following the instructions on that site or on the "Submit a Proxy to Vote by Internet" instructions on the enclosed proxy card.
|
|
|
2. |
You may submit a proxy to vote by telephone. You may submit a proxy to vote by calling 1-800-690-6903 and following the instructions provided, or by following the "Submit a Proxy to Vote by Phone" instructions on the enclosed proxy card.
|
|
|
3. |
You may submit a proxy to vote by mail. If you received a printed copy of the proxy materials by mail and would like to submit a proxy
to vote by mail, you need to complete, date and sign the proxy card that accompanies this proxy statement and promptly mail it in the enclosed postage-prepaid envelope. You do not need to put a stamp on the enclosed envelope if you mail it in the United States. The persons named on the proxy card will vote the shares you own in accordance with your instructions on the proxy card you mail. If you sign and return the proxy card, but do not give any instructions on a particular matter described in this proxy statement, the persons named on the proxy card will vote the shares you own in accordance with the recommendations of our board of directors.
|
|
|
4. |
You may vote your shares online while virtually attending the Special Meeting. You will be able to attend the Special Meeting online,
vote your shares online during the Special Meeting and submit your questions online during the Special Meeting by visiting www.virtualshareholdermeeting.com/CRIS2026SM3. You will need your control number included on your proxy card in order to be able to vote during the Special Meeting.
|
|
|
By Order of the Board of Directors,
|
|
|
|
|
|
James E. Dentzer
|
|
|
President and Chief Executive Officer
|
|
|
|
|
Lexington, Massachusetts
|
|
|
|
|
|
[____], 2026
|
|
|
TABLE OF CONTENTS
|
||
|
INFORMATION ABOUT THE SPECIAL MEETING AND VOTING
|
1
|
|
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
|
5
|
|
|
PROPOSAL 1 - ADOPTION AND APPROVAL OF AMENDMENTS TO OUR RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO EFFECT A REVERSE STOCK SPLIT
|
9 | |
|
Criteria to be Used for Decision to Apply the Reverse Stock Split
|
9 | |
|
Background and Reasons for the Reverse Stock Split
|
10 | |
|
Certain Risks Associated with the Reverse Stock Split
|
10 | |
|
Reservation of Right to Abandon the Amendments to our Restated Certificate of Incorporation and the Reverse Stock Split
|
11 | |
|
Procedure for Implementing the Reverse Stock Split
|
11 | |
|
Effect of the Reverse Stock Split on Holders of Outstanding Common Stock
|
11 | |
|
Beneficial Holders of Common Stock (i.e. stockholders who hold in street name)
|
13 | |
|
Registered "Book-Entry" Holders of Common Stock (i.e. stockholders that are registered on our transfer agent's books and records but do not hold stock certificates)
|
13 | |
|
Exchange of Stock Certificates
|
13 | |
|
Fractional Shares
|
14 | |
|
Effect of the Reverse Stock Split on Warrants, Options and Restricted Stock Awards
|
14 | |
|
No Appraisal Rights
|
15 | |
|
Accounting Matters
|
15 | |
|
Material U.S. Federal Income Tax Consequences of the Reverse Stock Split
|
15 | |
|
Board Recommendation
|
16 | |
|
PROPOSAL 2 - ADJOURNMENT PROPOSAL
|
17 | |
|
Board Recommendation
|
17 | |
|
OTHER MATTERS
|
17 | |
|
Solicitation of Proxies
|
17 | |
|
Householding of Annual Meeting Materials
|
18 | |
|
APPENDIX
|
||
|
Appendix A - Certificate of Amendment of Restated Certificate of Incorporation
|
A-1
|
|
|
|
1. |
To adopt and approve amendments to our Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our shares of common stock, by a ratio ranging from any whole number between 1-for-5 and 1-for-12, as determined by our Board of Directors (the "Board") in its discretion, subject to the Board's authority to abandon such amendments (the "Reverse Stock Split Proposal"); and
|
|
|
2. |
To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation of proxies in the event that there are insufficient votes for, or otherwise in connection with, the adoption and approval of Proposal 1.
|
|
|
1. |
Over the Internet. If you have Internet access, you may submit a proxy to vote your shares from any location in the world at www.proxyvote.com, by following the instructions on that site or the "Submit Your Proxy to Vote by Internet" instructions on the enclosed proxy card.
|
|
|
2. |
By telephone. You may submit a proxy to vote your shares by calling 1-800-690-6903 and following the instructions provided, or by following the "Submit Your Proxy to Vote by Phone" instructions on the enclosed proxy card.
|
|
|
3. |
By mail. If you received a printed copy of the proxy materials by mail and would like to submit a proxy to vote by mail, you need to complete, date and sign the proxy card that accompanies this proxy statement and promptly mail it in the enclosed postage-prepaid envelope. You do not need to put a stamp on the enclosed envelope if you mail it in the United States. The persons named on the proxy card will vote the shares you own in accordance with your instructions on the proxy card you mail. If you return and sign the proxy card, but do not give any instructions on a particular matter described in this proxy statement, the persons named on the proxy card will vote the shares you own in accordance with the recommendations of our board of directors.
|
|
|
4. |
Online while virtually attending the special meeting. You will be able to attend the Special Meeting online, vote your shares online during the Special Meeting and submit your questions online during the Special Meeting by visiting www.virtualshareholdermeeting.com/CRIS2026SM3. You will need your control number included on your proxy card in order to be able to vote during the Special Meeting.
|
|
|
1. |
Over the Internet or by Telephone. You will receive instructions from your bank, brokerage firm or other nominee if they permit you to submit voting instructions over the Internet or by telephone. You should follow those instructions.
|
|
|
2. |
By Mail. You will receive instructions from your bank, brokerage firm or other nominee explaining how you can submit voting instructions by mail. You should follow those instructions.
|
|
|
3. |
Online While Virtually Attending the Special Meeting. You will receive instructions from your bank, brokerage firm or other nominee explaining how you can vote your shares online during the Special Meeting. You will need your control number included on your voting instruction form in order to demonstrate proof of beneficial ownership and to be able to vote during the Special Meeting. Instructions on how to attend and participate online, including how to demonstrate proof of stock ownership, are posted at www.virtualshareholdermeeting.com/CRIS2026SM3.
|
|
|
• |
signing and returning another proxy card with a later date;
|
|
|
• |
giving our corporate secretary written notice before the Special Meeting that you want to revoke your proxy; or
|
|
|
• |
voting online while virtually attending the Special Meeting.
|
|
•
|
each person known to us to beneficially own more than 5% of the outstanding shares of our common stock;
|
|
•
|
each of our directors;
|
|
•
|
each of our named executive officers and
|
|
•
|
all directors and executive officers as a group.
|
|
|
Number of
Shares Held (1)
|
|
Shares Acquirable
Within 60 Days (2)
|
|
Number of Shares
Beneficially
Owned
|
Percent of
Shares
Beneficially
Owned (3)
|
|
|
Name and Address of Beneficial Owner
|
+
|
=
|
|||||
|
5% Stockholders:
|
|||||||
|
Entities affiliated with Bleichroeder LP (4)
|
56,784
|
684,526
|
741,310
|
9.99%
|
|||
|
Stonepine Capital, LP (5)
|
185,224
|
556,088
|
741,312
|
9.99%
|
|||
|
Pointillist Partners LLC (6)
|
199,694
|
400,307
|
600,001
|
8.24%
|
|||
|
Entities affiliated with Thomas A. Satterfield, Jr. (7)
|
165,877
|
290,065
|
455,942
|
6.39%
|
|||
|
Directors and Named Executive
|
|||||||
|
Officers:
|
|||||||
|
Anne E. Borgman, M.D.
|
⸺
|
1,285
|
1,285
|
*
|
|||
|
Martyn D. Greenacre
|
66
|
2,482
|
2,548
|
*
|
|||
|
John A. Hohneker, M.D.
|
⸺
|
1,502
|
1,502
|
*
|
|||
|
Kenneth I. Kaitin, Ph.D.
|
571
|
2,482
|
3,053
|
*
|
|||
|
Marc Rubin, M.D. (8)
|
1,406
|
5,150
|
6,556
|
*
|
|||
|
James E. Dentzer (9)
|
7,437
|
36,442
|
43,879
|
*
|
|||
|
Jonathan B. Zung, Ph.D. (10)
|
3,334
|
11,771
|
15,105
|
*
|
|||
|
Ahmed Hamdy, MBBCH (11)
|
3,334
|
9,793
|
13,127
|
*
|
|||
|
Diantha Duvall (13)
|
3,886
|
13,146
|
17,032
|
*
|
|||
|
All current directors and executive
|
|||||||
|
officers as a group (9 persons)
|
20,034
|
84,053
|
104,087
|
1.54%
|
| * |
Less than 1% of the outstanding common stock.
|
| (1) |
None of our directors or named executive officers has pledged any of their shares as security.
|
| (2) |
Shares Acquirable Within 60 Days include the following: (i) shares of common stock issuable upon exercise of pre-funded warrants issued in connection with October 2026 private placement or October 2026 Pre-Funded Warrants, our August 2026 public offering or August 2026 Pre-Funded Warrants, our January 2026 private placement or January 2026 Pre-Funded Warrants, our July 2025 private placement or July 2025 Pre-Funded Warrants and our March 2025 private placement or March 2025 Pre-Funded Warrants; (ii) shares of common stock issuable upon exercise of warrants issued in connection with our October 2026 private placement or October 2026 Warrants, August 2026 public offering or August 2026 Warrants, our January 2026 private placement or January 2026 Series A Warrants, our January 2026 private placement or January 2026 Series C Warrants, our July 2025 private placement or July 2025 Warrants and our March 2025 private placement or March 2025 Warrants and our October 2024 private placement or October 2024 Warrants; and (iii) shares of common stock issuable upon exercise of options issued pursuant to the Company's 2010 Stock Incentive Plan and the 2026 Incentive Plan.
|
| (3) |
The percent of ownership for each stockholder on October 20, 2026 is calculated by dividing (1) the stockholder's total beneficial ownership (i.e., the total number of shares beneficially owned plus the shares acquirable within 60 days) by (2) the sum of (i) 6,679,229 shares of our common stock that were outstanding on October 20, 2026 and (ii) shares acquirable by such stockholder within 60 days of October 20, 2026.
|
| (4) |
Entities affiliated with Bleichroeder LP: This information is based on information known to us. The shares reported under "Number of Shares Held" consist of shares of common stock held by 21 April Fund, L.P. and 21 April Fund, Ltd.
|
|
21 April
Fund LP
|
21 April
Fund Ltd.
|
The Nina
Gorrissen
2014 Trust
fbo Michael
M. Kellen
and his
Descendants
|
Total
|
||||
|
October 2026 Pre-Funded Warrants
|
178,544
|
396,291
|
-
|
574,835
|
|||
|
August 2026 Pre-Funded Warrants
|
24,157
|
54,021
|
27,363
|
105,541
|
|||
|
July 2025 Pre-Funded Warrants
|
1,003
|
2,219
|
-
|
3,222
|
|||
|
March 2025 Pre-Funded Warrants
|
297
|
631
|
-
|
928
|
|
21 April
Fund LP
|
21 April
Fund Ltd.
|
The Nina
Gorrissen
2014 Trust
fbo Michael
M. Kellen
and his
Descendants
|
Total
|
||||
|
October 2026 Pre-Funded Warrants
|
2,866,556
|
6,362,533
|
-
|
9,229,089
|
|||
|
August 2026 Pre-Funded Warrants
|
387,843
|
867,312
|
439,304
|
1,694,459
|
|||
|
July 2025 Pre-Funded Warrants
|
16,103
|
35,621
|
-
|
51,724
|
|||
|
March 2025 Pre-Funded Warrants
|
4,760
|
10,116
|
-
|
14,876
|
|||
|
October 2026 Warrants
|
3,045,100
|
6,758,824
|
-
|
-
|
|||
|
August 2026 Warrants
|
412,000
|
921,333
|
439,304
|
1,772,637
|
|||
|
January 2026 Series A Warrants
|
40,934
|
92,400
|
-
|
133,334
|
|||
|
January 2026 Series C Warrants
|
40,934
|
92,400
|
-
|
133,334
|
|||
|
July 2025 Warrants
|
17,106
|
37,840
|
-
|
54,946
|
|||
|
March 2025 Warrants
|
26,598
|
56,521
|
-
|
83,119
|
|||
|
October 2024 Warrants
|
7,929
|
16,849
|
-
|
24,778
|
| (5) |
Entities affiliated with Stonepine Capital LP: This information is based on the Schedule 13G filed with the SEC on March 27, 2026 by Stonepine Capital Management, LLC, adjusted for 1-for-20 reverse stock split effected on July 2, 2026 as well as information otherwise known to us. The shares reported under "Number of Shares Held" consist of 185,224 shares of common stock.
|
|
October 2026 Pre-Funded Warrants
|
556,088
|
|
October 2026 Pre-Funded Warrants
|
99,305
|
|
October 2026 Warrants
|
980,393
|
|
January 2026 Series A Warrants
|
166,667
|
|
January 2026 Series C Warrants
|
166,667
|
| (6) |
Pointillist Partners LLC: This information is based on the Registration Statement on Form S-3 that we filed with the SEC on February 13, 2026, which disclosed the beneficial ownership of Pointillist Partners LLC, adjusted for 1-for-20 reverse stock split effected on July 2, 2026 as well as information otherwise known to us.
|
|
January 2026 Pre-Funded Warrants
|
307
|
|
January 2026 Series A Warrants
|
200,000
|
|
January 2026 Series C Warrants
|
200,000
|
| (7) |
Entities affiliated with Thomas A. Satterfield, Jr: This information is based on the Schedule 13G filed with the SEC on May 14, 2026 by Thomas A. Satterfield, adjusted for 1-for-20 reverse stock split effected on July 2, 2026 as well as information otherwise known to us. The shares reported under "Number of Shares Held" consist of shares of common stock held by (i) A.G. Family L.P., a partnership managed by a general partner controlled by Mr. Satterfield, (ii) Tomsat Investment & Trading Co., Inc, a corporation wholly owned by Mr. Satterfield, (iii) The Thomas Adger Satterfield Jr. 2021 Revocable Trust controlled by Mr. Satterfield, and (iv) Caldwell Mill Opportunity Fund, LLC which fund is managed by an entity of which Mr. Satterfield owns a 50% interest and serves as Chief Investment Manager. The shares reported under "Shares Acquirable Within 60 Days" consist of the following:
|
|
A.G. Family
L.P.
|
Tomsat
Investment &
Trading Co.,
Inc.,
|
The Thomas
Adger
Satterfield Jr.
2021
Revocable
Trust
|
Total
|
||||
|
January 2026 Series A Warrants
|
50,000
|
33,334
|
16,667
|
100,001
|
|||
|
January 2026 Series C Warrants
|
50,000
|
33,334
|
16,667
|
100,001
|
|||
|
July 2025 Warrants
|
9,891
|
8,792
|
3,297
|
21,980
|
|||
|
March 2025 Warrants
|
31,162
|
10,388
|
16,620
|
58,170
|
|||
|
October 2024 Warrants
|
3,965
|
2,974
|
2,974
|
9,913
|
| (8) |
Marc Rubin: The shares reported under "Shares Acquirable Within 60 Days" consist of the following:
|
|
January 2026 Series A Warrants
|
1,334
|
|
January 2026 Series C Warrants
|
1,334
|
|
Options
|
2,482
|
| (9) |
James E. Dentzer: The shares reported under "Shares Acquirable Within 60 Days" consist of the following:
|
|
January 2026 Series A Warrants
|
6,667
|
|
January 2026 Series C Warrants
|
6,667
|
|
Options
|
23,108
|
| (10) |
Jonathan Zung: The shares reported under "Shares Acquirable Within 60 Days" consist of the following:
|
|
January 2026 Series A Warrants
|
3,334
|
|
January 2026 Series C Warrants
|
3,334
|
|
Options
|
5,103
|
| (11) |
Ahmed Hamdy: The shares reported under "Shares Acquirable Within 60 Days" consist of the following:
|
|
January 2026 Series A Warrants
|
3,334
|
|
January 2026 Series C Warrants
|
3,334
|
|
Options
|
3,125
|
| (12) |
Diantha Duvall: The shares reported under "Shares Acquirable Within 60 Days" consist of the following:
|
|
January 2026 Series A Warrants
|
3,334
|
|
January 2026 Series C Warrants
|
3,334
|
|
Options
|
6,478
|
|
|
• |
Nasdaq's minimum price per share requirements and its other listing requirements such as requirements relating to the minimum number of holders;
|
|
|
• |
the historical trading prices and trading volume of our common stock;
|
|
|
• |
the number of shares of our common stock outstanding prior to and after the Reverse Stock Split;
|
|
|
• |
the then-prevailing and expected trading prices and trading volume of our common stock and the anticipated or actual impact of the Reverse Stock Split (including the reduction in the number of outstanding shares) on the trading prices and trading volume for our common stock;
|
|
|
• |
the anticipated impact of a particular ratio on our ability to reduce administrative and transactional costs;
|
|
|
• |
business developments affecting us; and
|
|
|
• |
prevailing general market and economic conditions.
|
|
|
(i) |
the number of shares of our common stock that would be issued and outstanding;
|
|
|
(ii) |
the number of shares of our common stock that would be reserved for issuance pursuant to outstanding
|
|
|
a. |
pre-funded warrants;
|
|
|
b. |
warrants issued in connection with October 2024 Private Placement and the exercise price of such outstanding warrants;
|
|
|
c. |
warrants issued in connection with March 2025 Private Placement and the exercise price of such outstanding warrants;
|
|
|
d. |
warrants issued in connection with July 2025 Private Placement and the exercise price of such outstanding warrants;
|
|
|
e. |
warrants issued in connection with January 2026 PIPE Financing and such exercise price of the outstanding warrants, subject to conditions defined in the financing agreement;
|
|
|
f. |
warrants issued in connection with August 2026 Public Offering and such exercise price of the outstanding warrants, subject to conditions defined in the financing agreement;
|
|
|
g. |
warrants issued in connection with October 2026 Private Placement and such exercise price of the outstanding warrants, subject to conditions defined in the financing agreement;
|
|
|
(iii) |
the number of shares of our common stock that would be reserved for future issuance under our 2026 Incentive Plan;
|
|
(iv)
|
the number of shares of our common stock that would be reserved for future issuance under our Amended and Restated 2010 Employee Stock Purchase Plan, as amended;
|
|
(v)
|
the number of shares of our common stock that would be reserved for issuance pursuant to outstanding
|
|
|
a. |
restricted stock units; and
|
|
|
b. |
options and the weighted-average exercise price of outstanding options;
|
|
each giving effect to the Reverse Stock Split, without giving effect to any adjustments for fractional shares.
|
Before
|
Reverse
|
Reverse
|
|||||||||
|
Reverse
|
Stock
|
Stock
|
||||||||||
|
Stock Split
|
Split Ratio
|
Split Ratio
|
||||||||||
|
of 1-for-5
|
of 1-for-12
|
|||||||||||
|
Common Stock Authorized
|
567,514,300
|
567,514,300
|
567,514,300
|
|||||||||
|
Common Stock
|
6,679,229
|
1,335,846
|
556,603
|
|||||||||
|
Pre-Funded Warrants
|
15,964,140
|
3,192,828
|
1,064,276
|
|||||||||
|
Pre-funded Warrants Exercise Price
|
$
|
0.01
|
$
|
0.05
|
$
|
0.15
|
||||||
|
October 2024 Common Warrants
|
119,933
|
23,987
|
7,996
|
|||||||||
|
October 2024 Common Warrants Exercise Price
|
$
|
98.40
|
$
|
492.00
|
$
|
1476.00
|
||||||
|
March 2025 Common Warrants
|
415,846
|
83,170
|
27,724
|
|||||||||
|
March 2025 Common Warrants Exercise Price
|
$
|
48.20
|
$
|
241.00
|
$
|
723.00
|
||||||
|
July 2025 Common Warrants
|
153,854
|
30,771
|
10,257
|
|||||||||
|
July 2025 Common Warrants Exercise Price
|
$
|
43.00
|
$
|
215.00
|
$
|
645.00
|
||||||
|
January 2026 Common Warrants
|
2,692,692
|
538,539
|
179,513
|
|||||||||
|
January 2026 Common Warrants Exercise Price
|
$
|
8.97
|
$
|
44.87
|
$
|
134.62
|
||||||
|
August 2026 Common Warrants
|
3,733,334
|
746,667
|
248,889
|
|||||||||
|
August 2026 Common Warrants Exercise Price
|
$
|
0.60
|
3.00
|
9.00
|
||||||||
|
October 2026 Common Warrants
|
16,666,680
|
3,333,336
|
1,111,112
|
|||||||||
|
October 2026 Common Warrants Exercise Price
|
$
|
0.60
|
3.00
|
9.00
|
||||||||
|
Reserved for Issuance Under the 2026 Incentive Plan
|
494,113
|
98,823
|
32,941
|
|||||||||
|
Reserve for Issuance Under the Amended and Restated 2010 Employee Stock Purchase Plan
|
25,000
|
5,000
|
1,667
|
|||||||||
|
Restricted stock units
|
4,261
|
853
|
285
|
|||||||||
|
Options
|
436,683
|
87,337
|
29,113
|
|||||||||
|
Options Weighted-Average Exercise Price
|
$
|
78.47
|
$
|
392.36
|
$
|
1,177.09
|
||||||
|
|
• |
an individual who is a citizen or resident of the United States;
|
|
|
• |
a corporation (or any other entity or arrangement treated as a corporation for U.S. federal income tax purposes) created or organized under the laws of the United States, any state thereof, or the District of Columbia;
|
|
|
• |
an estate, the income of which is subject to U.S. federal income tax regardless of its source; or
|
|
|
• |
a trust if (1) its administration is subject to the primary supervision of a court within the United States and all of its substantial decisions are subject to the control of one or more "United States persons" (within the meaning of Section 7701(a)(30) of the Code), or (2) it has a valid election in effect under applicable U.S. Treasury regulations to be treated as a United States person.
|
|
|
• |
Financial institutions;
|
|
|
• |
Insurance companies;
|
|
|
• |
Real estate investment trusts;
|
|
|
• |
Regulated investment companies;
|
|
|
• |
Grantor trusts;
|
|
|
• |
Tax-exempt organizations;
|
|
|
• |
Dealers or traders in securities, commodities or currencies;
|
|
|
• |
Stockholders who hold common stock as part of a position in a straddle or as part of a hedging, conversion or integrated transaction for U.S. federal income tax purposes or U.S. holders that have a functional currency other than the U.S. dollar; or
|
|
|
• |
Stockholders who actually or constructively own 10% or more of our voting stock.
|
|
CURIS, INC.
|
|
|
|
|
|
|
|
By: James E. Dentzer
|
||
|
Title: President and Chief Executive Officer
|
||